Pharmaceutical News

RSS

The dangers of fraudulent diabetes products and how to avoid them

As the number of people diagnosed with diabetes continues to grow, an increasing number of products marketed under the guise of "dietary supplements" or "over-the-counter drugs" promising to prevent, treat, and even cure diabetes are being sold illegally.

21 Feb 2025

How to identify and avoid fraudulent Alzheimer's treatments

Chances are, you know someone with Alzheimer's disease or a related dementia involving memory loss.

21 Feb 2025

Study reveals dramatic rise in ivermectin and hydroxychloroquine prescriptions during COVID-19

U.S. outpatient prescriptions for hydroxychloroquine and ivermectin increased 2- to 10-fold above pre-pandemic rates, respectively, to treat COVID-19, despite strong evidence disproving their effectiveness, new UCLA-led research shows.

21 Feb 2025

Understanding the impact of weight loss medications on female reproductive health

In recent months, the efficacy of contraception for people taking weight loss medications has been questioned, as several women claim to have gotten pregnant despite using oral contraceptives.

21 Feb 2025

Blood pressure medication amlodipine shows promise in treating ADHD symptoms

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the University of Surrey.

20 Feb 2025

Key safety tips for older adults taking medications

Whether you're settling into your 60s or heading into your 90s, be careful when taking medicines, herbal preparations and supplements.

20 Feb 2025

Vitamin E significantly improves liver health in MASH patients, new study finds

A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in patients with MASH, with no major safety concerns reported.

19 Feb 2025

Exploring ketamine's potential in the fight against treatment-resistant depression

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

19 Feb 2025

Tampere University licenses drug for Epidermolysis Bullosa to Theravia

Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin disorders, to Theravia, a pharmaceutical company headquartered in the Paris region of France.

19 Feb 2025

Generic drugs from India linked to more severe adverse events

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds.

19 Feb 2025

Regulatory crackdown on online prescriptions of weight-loss drugs

Online pharmacies must now conduct in-person consultations before dispensing weight-loss medications, ensuring safe and appropriate use of high-risk drugs.

19 Feb 2025

Medicare Part D beneficiaries face rising out-of-pocket costs for brand name drugs The Expe...

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, according to new research from the USC Schaeffer Center for Health Policy & Economics published in JAMA.

19 Feb 2025

FDA-approved osteoporosis drug may treat rare genetic heart disease

A research team co-led by scientists at the University of Arizona College of Medicine – Tucson found that an osteoporosis drug might counter a rare genetic mutation underlying a type of heart disease.

18 Feb 2025

Cancer-free for 18 years: CAR-T therapy sets new milestone in neuroblastoma treatment

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children with neuroblastoma, with one patient remaining cancer-free for over 18 years.

17 Feb 2025

Lecanemab and donanemab slow Alzheimer’s decline, but is the benefit worth the cost?

Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily activities by up to 13 months, though their clinical relevance remains debated.

17 Feb 2025

Icaritin softgel capsules offer new hope for hepatocellular carcinoma patients

Announcing a new publication for Acta Materia Medica journal. Icaritin (ICA) is a prenylflavonoid natural product extracted from plants of the Epimedium genus.

17 Feb 2025

Diabetes drugs may boost brain health but experts warn of risks

Researchers reviewed 374 studies to explore how GLP-1RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent results for mood disorders.

16 Feb 2025

Prozac's surprising immune-boosting effects could lead to new treatments for sepsis

Antidepressants like Prozac are commonly prescribed to treat mental health disorders, but new research suggests they could also protect against serious infections and life-threatening sepsis.

14 Feb 2025

Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for adults with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy, irrespective of PD-L1 expression level or tumor histology.

14 Feb 2025

Risk of bleeding with blood thinners reduces over time

Blood thinners prescribed after blood clots in leg or lung initially increase the risk of bleeding, especially in women and elderly.

14 Feb 2025

Previous
1
...
5
6
7
8
9
10
11
...
1447
Next

Pharmaceutical News

The dangers of fraudulent diabetes products and how to avoid them

How to identify and avoid fraudulent Alzheimer's treatments

Study reveals dramatic rise in ivermectin and hydroxychloroquine prescriptions during COVID-19

Understanding the impact of weight loss medications on female reproductive health

Blood pressure medication amlodipine shows promise in treating ADHD symptoms

Key safety tips for older adults taking medications

Vitamin E significantly improves liver health in MASH patients, new study finds

Exploring ketamine's potential in the fight against treatment-resistant depression

Tampere University licenses drug for Epidermolysis Bullosa to Theravia

Generic drugs from India linked to more severe adverse events

Regulatory crackdown on online prescriptions of weight-loss drugs

Medicare Part D beneficiaries face rising out-of-pocket costs for brand name drugs The Expe...

FDA-approved osteoporosis drug may treat rare genetic heart disease

Cancer-free for 18 years: CAR-T therapy sets new milestone in neuroblastoma treatment

Lecanemab and donanemab slow Alzheimer’s decline, but is the benefit worth the cost?

Icaritin softgel capsules offer new hope for hepatocellular carcinoma patients

Diabetes drugs may boost brain health but experts warn of risks

Prozac's surprising immune-boosting effects could lead to new treatments for sepsis

Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer

Risk of bleeding with blood thinners reduces over time

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News